Abstract

Vasoactive intestinal peptide (VIP) is a prominent neuropeptide whose actions are mediated by VPAC receptors belonging to class II G protein-coupled receptors. To identify contact sites between VIP and its VPAC1 receptor, an analog of VIP substituted with a photoreactive para-benzoyl-l-Phe (Bpa) at position 22 has been synthesized and evaluated in Chinese hamster ovary cells stably expressing the recombinant human receptor. Bpa22-VIP and native VIP are equipotent in stimulating adenylyl cyclase activity in cell membranes. Cyanogen bromide cleavage of the covalent 125I-[Bpa22-VIP]-hVPAC1R complex yielded a single labeled fragment of 30 kDa that shifted to 11 after deglycosylation, most consistent with the 67-137 fragment of the receptor N-terminal ectodomain. Further cleavage of this fragment with V8 endoproteinase and creation of receptor mutants with new CNBr cleavage sites (XàMet), demonstrated that 125I-[Bpa22-VIP] was covalently attached to the short receptor 109-120 fragment (GWTHLEPGPYPI). In a three-dimensional model of the receptor N-terminal ectodomain, this fragment is located on one edge of the putative VIP binding groove and encompasses several amino acids previously shown to be crucial for VIP binding (reviewed in Laburthe, M., Couvineau, A., and Marie, J. C. (2002) Receptors Channels 8, 137-153). Our data provide the first direct evidence for a physical contact between VIP and the N-terminal ectodomain of the hVPAC1 receptor.

Highlights

  • Vasoactive intestinal peptide (VIP)1 is a prominent neuropeptide present in the central and peripheral nervous systems as well as in immune cells [1,2,3]

  • This site of incorporation of the benzophenone group, a photoactivable group of choice for high efficiency covalent labeling of proteins [14], was selected for several reasons. (i) Tyr22 is present in the central part of the 28-amino acid VIP, a domain that has been shown previously by alanine scanning to contain several amino acids that are crucial for VIP binding [15]. (ii) Alanine scanning showed that Tyr22 itself is not important for the biological activity of VIP [15], and we expected that incorporation of Bpa in this position would result in a high affinity probe. (iii) The substitution of Bpa for tyrosine keeps an aromatic residue

  • The synthetic Bpa22-VIP photoaffinity probe developed in this study was first evaluated for its ability to interact with the human VPAC1 receptor stably expressed in CHO-F7 cells

Read more

Summary

Introduction

Vasoactive intestinal peptide (VIP)1 is a prominent neuropeptide present in the central and peripheral nervous systems as well as in immune cells [1,2,3]. The synthetic Bpa22-VIP photoaffinity probe developed in this study was first evaluated for its ability to interact with the human VPAC1 receptor stably expressed in CHO-F7 cells.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call